NO activity in familial combined hyperlipidemia: potential role of cholesterol remnants

Cardiovascular Research
E S StroesT J Rabelink

Abstract

Patients with familial combined hyperlipidemia (FCH) have an increased cardiovascular mortality despite only moderate elevations of LDL-cholesterol. Since endothelial NO release is intimately involved in the anti-atherosclerotic effects of the endothelium, we studied the effect of short-term lipid-lowering therapy on NO-mediated vasodilatation in patients with FCH. In view of only moderate LDL elevations, we evaluated whether alterations in other lipid fractions upon therapy correlated to changes in NO-mediated vasodilatation. NO activity was assessed by serotonin-induced, nitric oxide-mediated increase in forearm blood flow (FBF). Measurements were performed 2 weeks off and 4 weeks on lipid-lowering therapy in 12 FCH patients using forearm venous occlusion plethysmography. Control experiments were performed in 12 healthy subjects. Serotonin-induced vasodilatation was impaired in FCH patients (FBF (unit ml/100 ml forearm tissue/min) from 3.0 (0.3) to 4.8 (0.4)) compared to controls (FBF from 2.9 (0.3) to 6.5 (0.6); p < 0.05 vs. FCH). FBF response to serotonin improved significantly upon lipid-lowering therapy (from 3.0 (0.3) to 5.7 (0.5); p < 0.05 treated vs. untreated). The level of improvement in endothelial function was sign...Continue Reading

Citations

Jul 7, 2001·Journal of the Neurological Sciences·B Cucchiara, S E Kasner
Jun 12, 2003·Psychiatry Research·George I PapakostasMaurizio Fava
Mar 12, 2004·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·George I PapakostasMaurizio Fava
Oct 26, 2013·Journal of Applied Physiology·Vincent J de BeerM Harold Laughlin
May 19, 2010·Biomarkers in Medicine·Bernhard R WinkelmannMartin Unverdorben
Oct 4, 2005·Current Medical Research and Opinion·Ewoud ter AvestAnton F H Stalenhoef
Jul 21, 1999·Kidney International. Supplement·J A JolesT J Rabelink
Nov 26, 2008·Pharmacology, Biochemistry, and Behavior·Perry F RenshawWilliam A Carlezon
Apr 18, 2008·Thrombosis Research·David KarásekDalibor Novotný
Nov 16, 2004·The American Journal of Medicine·Ethan M BalkJoseph Lau
Apr 28, 2007·European Journal of Clinical Investigation·E Ter AvestJ de Graaf
Oct 23, 2002·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·W MlekuschE Minar
Sep 14, 2002·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Jun R Chiong, Alan B Miller
Apr 30, 2009·Journal of Hypertension·Martijn C G J BrouwersCoen D A Stehouwer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.